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Bifunctional RNAs that possess both protein-coding and noncoding functional properties were less explored and poorly
understood. Here we systematically explored the characteristics and functions of such human bifunctional RNAs by integrating
tandem mass spectrometry and RNA-seq data. We first constructed a pipeline to identify and annotate bifunctional RNAs,
leading to the characterization of 132 high-confidence bifunctional RNAs. Our analyses indicate that bifunctional RNAs may be
involved in human embryonic development and can be functional in diverse tissues. Moreover, bifunctional RNAs could interact
with multiple miRNAs and RNA-binding proteins to exert their corresponding roles. Bifunctional RNAs may also function as
competing endogenous RNAs to regulate the expression of many genes by competing for common targeting miRNAs. Finally,
somatic mutations of diverse carcinomas may generate harmful effect on corresponding bifunctional RNAs. Collectively,
our study not only provides the pipeline for identifying and annotating bifunctional RNAs but also reveals their important
gene-regulatory functions.
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INTRODUCTION
The human genome encodes diverse protein-coding and non-
coding RNAs (ncRNAs). In general, ncRNAs do not translate
into proteins and the number of ncRNAs is much larger than
that of protein-coding RNAs (Derrien et al., 2012). ncRNAs
can be roughly divided into small (<200 nt) and long (³200
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nt) ncRNAs according to their lengths with an arbitrary cutoff
of 200 nt. However, based on the relative genomic locations
between ncRNAs and protein-coding genes, ncRNAs could
be further classified into different categories including biodi-
rectional, intronic, antisense and overlapped (Mercer et al.,
2009). Recently, a growing number of studies have indicated
that ncRNAs play crucial roles in chromatin remodeling, ge-
netic imprinting, cell cycle, alternative splicing, and mRNA
translation or degradation (Faghihi et al., 2008; Hung et al.,
2011; Tripathi et al., 2010; Tsai et al., 2010). Moreover, long
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ncRNAs (lncRNAs) are involved in the progression of many
cancers and some of them have been recognized as poten-
tial biomarkers for tumor prevention, prognosis or treatment
(Batista and Chang, 2013; Esteller, 2011; Hu et al., 2014).
Intriguingly, a portion of RNAs termed as bifunctional
RNAs possess two distinct functions. Some bifunctional
RNAs have the capacity to function as two different ncRNAs
(Ender et al., 2008), whereas some others have the potential
to function as ncRNAs or encode peptides/proteins (Dinger
et al., 2008). Several important examples regarding how bi-
functional RNAs exert their ncRNA/protein roles have been
reported in Xenopus (Kloc et al., 2005), Drosophila (Jenny
et al., 2006), Escherichia coli (Vanderpool and Gottesman,
2004; Wadler and Vanderpool, 2007) and human (Anderson
et al., 2015; Chooniedass-Kothari et al., 2004; Lanz et al.,
1999). Using the tandem mass spectrometry (MS/MS) and
RNA-seq data of K562 and GM12878 cell lines, Bánfai et
al. identified a small number of translatable lncRNAs as bi-
functional RNAs (Banfai et al., 2012). A recently published
paper of the human proteome also indicates that a portion
of ncRNAs and pseudogenes may be translatable as seen
from matched peptides (Kim et al., 2014). Furthermore, by
analyzing the sequencing data of corresponding ribosome
profiling, Ruiz-Orera et al. found that many lncRNAs of six
distinct species were correlated with ribosomes and might
be crucial for the de novo evolution of proteins (Ruiz-Orera
et al., 2014). However, to date, the existence and functions
of bifunctional RNAs that can function independently as
ncRNA or encode functional proteins remain to be largely
underexplored. Due to the uncertainty expressions of RNAs
and proteins (Chen et al., 2013), it is crucial to identify
and characterize those mysterious bifunctional RNAs by
combing tandem mass spectrometry (MS/MS) and RNA-seq
data.
In this study, by integrating diverse MS/MS and RNA-seq
data, we identified 132 high-confidence bifunctional RNAs
that have both noncoding and protein-coding capacity and
systematically annotated their functions from distinct aspects.
First, we constructed a pipeline for identifying bifunctional
RNAs based on MS/MS data and reassessing their coding
potential. Secondly, we interrogated the characteristics and
potential functions of the encoded proteins for those bifunc-
tional RNAs. Thirdly, we examined the expression profiles of
those bifunctional RNAs in early human embryos and a large
number of diverse human tissues. Fourthly, by construct-
ing networks of ncRNA-miRNA and ncRNA-protein inter-
actions, we determined the interactions between bifunctional
RNAs and miRNAs and proteins, respectively. Fifthly, we
noted that a portion of bifunctional ncRNAs might be func-
tional as competing endogenous RNAs (ceRNAs) to influ-
ence the expression of relevant genes including multiple can-
cer related ones. Finally, we found that most of these bifunc-
tional RNAs could bematchedwith known somaticmutations
of various cancer types.
RESULTS
Identification of bifunctional RNAs based onMS/MS data
and reassessment of their coding potential
To accurately discriminate bifunctional RNAs from the rest
of ncRNAs, we first sought to construct a robust pipeline to
identify the bona fide translatable ncRNAs, i.e. bifunctional
RNAs. We parsed the MS/MS data of NCI-60 panel (includ-
ing 59 cancer cell lines of 9 distinct tissue types) (Gholami
et al., 2013) by employing TPP (Trans-Proteomic Pipeline)
(Deutsch et al., 2010) with X!Tandem (Keller et al., 2005) as
search engine (Figure 1). A protein database consisting of
Ensembl v75 proteins and the in silico translated proteins of
Ensembl ncRNAs (including pseudogenes) was established
for MS/MS data matching (see Methods). Using more
stringent criteria of protein probability >0.95 and at least one
unique peptide for an identified protein, we detected 720 ncR-
NAs meeting such thresholds. 482 of them were reclassified
as protein-coding RNAs using the effective Coding-Potential
Assessment Tool (CPAT) (Wang et al., 2013) and were
excluded from following analysis because they might be
resulted from the mis-annotation of Ensembl protein-coding
transcripts. The remaining 238 ncRNAs were still reassessed
with no coding potential. We further removed 106 ncRNAs
generated from protein-coding genes and genomic patch
sequences, which is important to minimize the false positives
of bifunctional RNA identification. Finally, 132 ncRNAs
were retained as high-confidence bifunctional RNAs and
none of them overlapped with those 15 ones identified by
Bánfai et al (Banfai et al., 2012) (Figure 1 and Table S1 in
Supporting Information). Furthermore, the possible mis-an-
notated ncRNAs are generally longer than those bifunctional
RNAs in length (Wilcoxon rank sum test, P=8.2×10–8) and
contain more exons in general (Table S2 in Supporting
Information) Most of the bifunctional RNAs identified in
each condition were also detected in other conditions of
NCI-60 cancer cell lines (Figure 2A). Particularly, 5 bi-
functional RNAs (ENST00000388966, ENST00000413899,
ENST00000429708, ENST00000462417 and ENST00000-
513224) were identified across all those 9 different NCI-60
tissue types.
The reliability of our pipeline was tested with literature data
on the identification of bifunctional RNAs. In a previous
study, 15 translatable lncRNAs (bifunctional RNAs) that still
remained in the updated gene set of Ensembl v75 we used in
this study were identified in cell lines K562 and GM12878
(FDR ≤10% for peptide identification) (Banfai et al., 2012).
Moreover, 47 lncRNAsmatched with peptides they identified
that still existed in Ensembl v75 were considered as the an-
notation error of protein-coding transcripts, we denoted them
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Figure 1   Pipeline for the identification and annotation of bifunctional RNAs. Bifunctional RNAs were identified by a series of steps with corresponding filters
based on MS/MS data and coding capacity reassessment. The ncRNAs encoded by the protein-coding genes and genomic patches were further removed to
minimize the false positives. The identified bifunctional RNAs were further characterized and annotated using RNA-seq data, network inference and related
databases.
as misclassified lncRNAs. We further reassessed the cod-
ing potential of those 62 lncRNAs (15 bifunctional RNAs
and 47 misclassified lncRNAs) with peptide matches using
CPAT (Wang et al., 2013). Interestingly, 2 of the 15 trans-
latable lncRNAs were reassessed as protein-coding and 11 of
those 47 misclassified lncRNAs were reassessed as non-pro-
tein-coding by CPAT. Thus, assuming the prior results are
correct, MS/MS data coupled with CPAT could effectively
identify the bifunctional RNAs (86.67%, 13 out of 15) and
misclassified lncRNAs (76.6%, 36 out of 47).
Bifunctional RNAs are shorter and encompass fewer
numbers of exons than protein-coding RNAs
Bifunctional RNAs are shorter in length (Wilcoxon rank
sum test, P=4.8×10–14) and contain fewer numbers of exons
(P<2.2×10–16) compared to protein-coding RNAs. Those 132
bifunctional RNAs are encoded by 109 non-protein-coding
genes,  some  of  which  encode  more than one bifunctional
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Figure 2   Statistics of bifunctional RNAs identified in the NCI-60 cancer cell lines. A, Distribution of bifunctional RNAs identified in each type of NCI-60
cancer cell lines. “Common” represents those bifunctional RNAs were identified in at least two types of NCI-60 cancer cell lines, whereas “Unique” denotes
those bifunctional RNAs were only identified in corresponding type of cells. B, Alternative splicing modes of 132 bifunctional RNAs. CNE, constitutive exon;
CE, cassette exon (exon skipping); Other, unclassified splicing mode; IR, intron retention; A5SS, alternative 5′ sites; A3SS, alternative 3′ sites; ALE, alternative
last exon. C, The biotypes of bifunctional RNAs annotated by Ensembl. D, Number of identified bifunctional RNAs on each chromosome.
RNAs, mainly through the splice events of constitutive ex-
ons (81) and exon skipping (31) (Figure 2B). Their lengths
range from 99 to 5,230 bp (median: 733.5 bp; mean: 1,073
bp), whereas the median (1,434 bp) and mean (2,036 bp)
lengths of protein-coding RNAs are twice longer (Ensembl
v75). Moreover, most (70.4%) of those bifunctional RNAs
consist of only one (54) or two (39) exons; however, the great
majority (91.8%) of protein-coding RNAs harbor more than 2
exons. Those 132 bifunctional RNAs could be classified into
diverse biotypes including processed pseudogene, antisense,
and lincRNA (long intergenic noncoding RNA) according to
Ensembl gene annotations (Figure 2C). In addition, they scat-
tered over 22 disparate human chromosomes (Figure 2D).
Bifunctional RNAs are partially conserved across species
and their encoded proteins are functional
Most of those bifunctional RNAs harbor conserved sequences
and the proteins encoded by them can be functionally im-
portant. We found that the exons of 104 out of the 132 bi-
functional RNAs overlapped with (at least one-base overlap)
the conserved elements across 46 vertebrates predicted by
phastCons (Siepel et al., 2005), suggesting that the sequences
of most of those bifunctional RNAs are partially conserved
across vertebrates. Moreover, functional enrichment analysis
for those bifunctional RNAs using Blast2GO suite (Gotz et
al., 2008) implied that their encoded proteins are mainly in-
volved in the biological processes of cell cycle, cell division,
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organelle fission, and organelle organization.
Bifunctional RNAs are expressed in human embryos and
various tissues
The expression level of genes could be an important aspect
to reflect their functions in correponding cells (Gout et al.,
2010; Vogel and Marcotte, 2012). To investigate the nature
of expression profiles for bifunctional RNAs, we explored
their expression in 2,916 samples across 53 tissue sites of
the GTEx (Genotyp-Tissue Expression) project (Lonsdale et
al., 2013) and 29 samples across 7 continuous early embry-
onic stages of human (Xue et al., 2013). The expression lev-
els of those bifunctional RNAs in the GTEx tissues were ex-
tracted from the transcript expression matrix provided by the
GTEx portal, whereas raw data of embryonic samples were
used to quantify the gene/transcript expression by employ-
ing TopHat2 (Kim et al., 2013) and Cufflinks (Trapnell et al.,
2010) (see Methods). We found that a small fraction of those
bifunctional RNAs was expressed in early embryos (Figure
3A); however, a large portion of them was expressed across
diverse tissues of the GTEx project (Figure 3B). Intriguingly,
the bifunctional RNAs with relatively high expression lev-
els in early embryos were expressed in various adult tissues
as well, implying that these bifunctional RNAs possess cer-
tain basic functions in human cells. On the other hand, bi-
fucntional RNAs only expressed in adult human tissues but
not in embryos showed spatio-temporal expression charac-
teristics and may mainly function in adult tissues. To inter-
rogate whether bifunctional RNAs significantly changed in
expression during embryonic development, we further con-
ducted differential expression calling between adjacent em-
bryonic stages (Trapnell et al., 2013). Interestingly, 2 bifunc-
tional RNAs (q value <0.05), i.e., ENST00000571336 and
ENST00000564694, were differentially expressed between
4-cell and 8-cell stages, suggesting that they are correlated
with human embryonic development.
In addition, according to the clustering of expression
profiles across different tissues, bifunctional RNAs can
be clearly classified into three categories (Figure 3B): (i)
those expressed with relatively high levels in most tissues
(shown with orange bar); (ii) those expressed at medium
levels in most tissues (shown with purple bar); and (iii) those
expressed only in a fraction of tissues in a tissue-specific
manner or no expression in any of those tissues (shown with
red bar). Overall, the results suggest that those bifunctional
RNAs may play important roles in human embryonic devel-
opment as well as in maintaining the normal physiological
functions for various adult tissues.
Bifunctional RNAs could interact with miRNAs, RNA-
binding proteins
To gain insights into the functions of those bifunctional
RNAs, we constructed the interaction networks of bifunc-
tional RNAs  with  miRNAs and proteins using the miRNA-
Figure 3   Expression profile of bifunctional RNAs in early human embryos and diverse tissues. A, Clustering of expression for bifunctional RNAs in 7 different
embryonic stages. B, Classification of bifunctional RNAs based on their expression in 2,916 samples across 53 tissue sites of the GTEx project. The bifunctional
RNAs were classified into three distinct groups with orange, purple and red bars, respectively.
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ncRNA and protein-ncRNA interactions cataloged in star-
Base v2.0 (Li et al., 2014). The resulting network of bifunc-
tional RNAs and miRNAs shows that 39 bifunctional RNA
genes interact with 141 miRNAs through 470 interactions
(Figure 4A). Furthermore, 35 out of the 39 bifunctional RNA
genes interact with at least 2 and 11 with 10 or more dis-
tinct miRNAs. Specifically, the two bifunctional RNA genes
ERVK3-1 and SDCBP2-AS1 form two hubs in the network
that separately interact with 114 and 75 miRNAs, respec-
tively. Notably, these two RNA genes could produce 6 or
5 bifunctional RNAs. On the other hand, 86 of those 141
miRNAs interact with 2 or more bifunctional RNAs, indicat-
ing that miRNAs and bifunctional RNAs interact mainly in a
many-to-many mode (Figure 4A).
The primary interaction mode between bifunctional RNAs
and RNA-binding proteins (RBPs) is many-to-many as well
(Figure 4B). Briefly, 71 bifunctional RNA genes bind to 26
RBPs to yield 264 interactions. Forty-eight out of the 71 bi-
functional RNA genes interact with 2 or more RBPs, while
24 RBPs bind to at least 2 bifunctional RNA genes. Sur-
prisingly, protein UPF1 (regulator of nonsense transcripts ho-
molog) has the greatest capacity to bind to 109 bifunctionl
RNAs. Functional annotation of these RBPs using DAVID
(Huang et al., 2008) indicates that they are mainly enriched in
post-transcriptional regulation of gene expression, regulation
of translation, gene silencing, and RNA processing (adjusted
P<0.01). Because lncRNAs have the ability to bind to cor-
responding proteins to regulate gene expression by modify-
ing the chromatin state (Mercer and Mattick, 2013), and thus,
bifunctional RNAs may also have regulatory roles through
binding to relevant proteins. These findings suggest that bi-
functional RNAsmay function similarly as lncRNAs to act as
targets of diverse miRNAs and RBPs to regulate the expres-
sion of associated genes.
miRNAs could target bifunctional RNAs
To further interrogate whether miRNAs are targeted by those
bifunctional RNAs in normal or cancer tissues of human, we
explored the expression correlation between miRNAs and
their targets in miRGator V3.0 (Cho et al., 2013). Expression
correlations of miRNA-RNA cataloged in miRGator were
calculated with the expression data of miRNA and RNA
from the same samples, which is crucial for minimizing
the biological bias. We used the genes of those bifunc-
tional RNAs for examining their expression correlation
with miRNAs, because the miRNA targets were archived
at the gene level in miRGator. With the threshold of ex-
pression correlation (Pearson’s correlation) r≤–0.3, 7 genes
(BTF3P13, EPS15P1, GTF2H2B, HAS2-AS1, SLC38A3,
UBXN8, and WASH6P) encoding 8 bifunctional RNAs
(WASH6P produced two) were negatively correlated with
relevant miRNAs in different types of cancers or normal cells
including kidney renal papillary cell carcinoma (KIRP), liver
hepatocellular carcinoma (LIHC), prostate cancer, leukemia,
human embryonic stem cells or brain (Figure 5). When
employing a more stringent cutoff of r≤–0.5, bifunctional
RNA genes EPS15P1, GTF2H2B, SLC38A3, and UBXN8
remained to show strong inverse expression correlation
with 6, 12, 109, and 135 miRNAs supported by at least
one data set used in miRGator, respectively. Specifically,
many of the strong negative correlations between miRNAs
and bifunctional RNAs expression were only observed in a
specific cancer or normal tissue, implying that bifunctional
RNAs functionally are targeted by distinct miRNAs under
different biological conditions. Accordingly, the results not
only further demonstrate the above finding that bifunctional
RNAs could function as the targets of multiple miRNAs,
but also imply the important regulatory roles of bifunctional
RNAs in human tumors.
Bifunctional RNAs may function as competing endoge-
nous RNAs
Considering the fact that a portion of lncRNAs may act as
competing endogenous RNAs (ceRNAs) by blocking miR-
NAs from binding to mRNAs (Cesana et al., 2011; Salmena
et al., 2011; Sumazin et al., 2011; Tay et al., 2011), we fur-
ther assessed whether the bifunctional RNAs identified in our
study can function as ceRNAs. The 132 identified bifunc-
tional RNAs were mapped to the ceRNA candidates docu-
mented in the lnCeDB database (Das et al., 2014) and 26
bifunctional RNAs were matched. In summary, those 26
bifunctional RNAs can act as ceRNAs to compete with re-
lated RNAs for 963 targeting miRNAs, which may result in
changes in expression levels of corresponding RNAs. More-
over, 22 out of those 26 bifunctional RNAs may function as
ceRNAs to interfere the pathways of 2 or more miRNAs and
9 of them can even be targeted by over 100 miRNAs. No-
tably, a miRNA usually targets hundreds of genes, thus we
observed that bifunctional RNAs could potentially influence
the miRNA mediated regulation of expression for thousands
of genes. Furthermore, 560 miRNAs could individually tar-
get at least 2 of those 26 bifunctional RNAs, suggesting that
bifunctional RNAs may cross-regulate each other by compet-
ing for shared targeting miRNAs.
To investigate whether those 26 candidate ceRNAs of
bifunctional RNAs have the potential to interfere the expres-
sion of human cancer related genes, we examined the target
genes of miRNAs associated with ceRNAs in cancer genes of
diverse tumors. First, a comprehensive human cancer gene
set (2,580 in total, including oncogenes, tumor suppressor
genes, driver or significantly mutated genes) was collected
from databases of NCG4.0 (An et al., 2014), TSGene (Zhao
et al., 2013) and two recent reports (including The Can-
cer Genome Atlas (TCGA)) regarding human pan-cancer
(Kandoth et al., 2013; Vogelstein et al., 2013). Interestingly,
the  majority  (2,355  out of 2,580)  of  these  cancer  genes
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Figure 4   Interactions between bifunctional RNAs and miRNAs or RBPs. A, Interaction network between bifunctional RNAs and miRNAs. B, Interaction
network between bifunctional RNAs and RBPs. Bifunctional RNAs, miRNAs and RBPs were shown in red ellipse, green diamond and yellow octagon, re-
spectively.
associated with various cancer types are the targets of 145
miRNAs that also could potentially target 8 of those 26 can-
didate ceRNAs (Figure 6). These 8 bifunctional RNAs could
be targeted by one or even dozens of miRNAs, while these
145 miRNAs would target one or hundreds of cancer genes.
Accordingly, the results suggest that bifunctional RNAs may
Chen, G., et al.   Sci China Life Sci   October (2016)  Vol. 59  No. 10 987
Figure 5   Count distribution of inverse expression correlation between miRNAs and bifunctional RNAs in different cancer or normal tissues. This figure shows
the number of negative expression correlation (r≤–0.3) between bifunctional RNAs and miRNAs in each data set obtained from miRGator V3.0 (Cho et al.,
2013), which could provide the evidence that miRNAs may target bifunctional RNAs to regulate their expression.
play important roles in diverse human cancers through affect-
ing the post-transcriptional regulation of cancer genes medi-
ated by common targeting miRNAs.
Disease/trait-associated variants and somatic mutations
influence bifunctional RNAs
To inquire whether these 132 bifunctional RNAs overlap
with known disease/trait-associated variants or cancer re-
lated somatic mutations, we examined the published GWAS
(genome-wide association studies) variants (Welter et al.,
2014) and the somatic mutations of diverse cancers cataloged
in the COSMIC database (Forbes et al., 2015). Intriguingly,
4 noncoding disease/trait-associated GWAS variants were
located in the exonic or intronic regions of 6 bifunctional
RNAs (Table S3 in Supporting Information). Moreover, we
identified 1,801 noncoding somatic mutations of various
tumor types within the exons or introns of 101 bifunctional
RNAs (Table S4 in Supporting Information). The involved
cancer types include the carcinomas of ovary, lung, breast,
kidney, and prostate studied in the TCGA project and so on.
Genetic variants in noncoding RNAs could be functionally
important and might influence the expression or biogenesis
of noncoding RNAs (Ward and Kellis, 2012). Thus, these
identified GWAS variations and somatic mutations could
generate harmful influences on relevant bifunctional RNAs
in corresponding disease/trait or tumors.
DISCUSSION
MS/MS data provide great opportunities to assess the coding
capacity of each transcript encode by the genome. We es-
tablished a pipeline to effectively identify and annotate the
human bifunctional RNAs based on MS/MS and RNA-seq
data. The precision ratio is ~0.87 based on testing the identi-
fied bifunctional RNAs reported in a previous study (Banfai
et al., 2012). Although we first detected 720 ncRNAs that
could be matched with unique peptides, the majority of them
might be resulted from mis-annotating protein-coding tran-
scripts as noncoding and were excluded. Only 132 ncRNAs
were finally assessed as high-confidence bifunctional RNAs
through a series of stringent filtering processes. Our results
show that a small portion of bifunctional RNAs were ex-
pressed in early human embryos; however, the majority of
those bifunctional RNAs (including the ones expressed in
embryos) were expressed in at least one adult tissue from
the GTEx project (Lonsdale et al., 2013). Thus, most of
those bifunctional RNAs would mainly function in adult tis-
sues. Furthermore, those bifunctional RNAs could be gener-
ally classified into three groups according to their expression
patterns in the huge number of samples from diverse tissue
types of the GTEx project. The first group exhibits high ex-
pression in almost all the tissues and their conserved expres-
sion implies that for different tissues they might be funda-
mental like house-keeping genes. Bifunctional RNAs in the
second group were broadly expressed in diverse tissues but
with relatively lower abundance and were not expressed in a
portion of the samples. Bifunctional RNAs in the third group
were only lowly expressed in a fraction of samples or not ex-
pressed at all. Accordingly, the expression of bifunctional
RNAs has spatio-temporal properties and could be important
for embryonic development and for maintaining the normal
physiological functions of diverse tissues.
Our findings indicate that bifunctional RNAs could be tar-
geted by miRNAs or proteins to regulate the expression of
corresponding genes including lots of cancer related genes.
By  constructing  the  interaction  networks  of  bifunctional
988 Chen, G., et al.   Sci China Life Sci   October (2016)  Vol. 59  No. 10
Figure 6   Interaction network among bifunctional RNAs, miRNAs and cancer genes of diverse tumors. Bifunctional RNA, miRNAs and cancer genes were
denoted as red ellipse, lime diamond and purple triangle, respectively. The cancer genes associated with various tumors were obtained by integrating those in
NCG4.0 (An et al., 2014) and TSGene (Zhao et al., 2013) databases as well as those reported in two recent human pan-cancer reports (Kandoth et al., 2013;
Vogelstein et al., 2013).
RNAs with miRNAs and proteins, we observed that many-to-
many is the main interaction mode for these two kinds of in-
teractions. Moreover, we also found evidences for support-
ing the interaction between bifunctional RNAs and miRNAs
in such a way that the expression of a number of miRNAs
was negatively correlatedwith that of some bifunctional RNA
genes in disparate human cancers or tissues. Besides, expres-
sion correlation between bifunctional RNAs andmiRNAs ex-
tracted frommiRGator (Cho et al., 2013) also suggests that bi-
functional RNAs might be targeted by different miRNAs un-
der distinct conditions. Interestingly, 26 bifuncational RNAs
have the potential to act as ceRNAs to interfere the expression
of corresponding genes by competing with the same targeting
miRNA.We also found that bifunctional RNAs can cross-reg-
ulate their expression with each other because some of them
share common targeting miRNAs. Specifically, the targeting
miRNAs for 2,355 cancer related genes also target bifunc-
tional RNAs, implying that bifunctional RNAs could function
as ceRNAs to regulate the expression of cancer genes in var-
ious cancers. In addition, most of these bifunctional RNAs
overlap with the somatic mutations from various cancers and
those involved mutations could adversely influence the corre-
sponding bifunctional RNAs to play certain roles in relevant
cancer.
In summary, we identified 132 high-confidence bifuctional
RNAs in the NCI-60 cancer cell lines and also characterized
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their potential functions in detail through integrative analy-
ses. Integrating the high-throughput data from MS/MS and
RNA-seq, as well as constructing networks for interactions
between bifunctional RNAs and miRNAs or proteins repre-
sent a promising strategy for identifying and annotating bi-
functional RNAs. To the best of our knowledge, our work
reported the first pipeline for systematically identifying and
annotating bifunctional RNAs. This pipeline can be applied
to further characterize more bifuncitonal RNAs in human or
other species.
MATERIALS AND METHODS
Identification of bifunctional RNAs
To identify human bifunctional RNAs, MS/MS data of the
NCI-60 cancer cell line panel from a previous study (Gholami
et al., 2013) were downloaded and processed. X!Tandem
(Keller et al., 2005) was employed as the database search
engine for TPP (Trans-Proteomic Pipeline, v4.6.1) (Deutsch
et al., 2010). Specifically, the MS/MS data were searched
against the non-redundant protein database comprising of En-
sembl proteins (version 75) and in silico translated Ensembl
ncRNAs using X!Tandem-native and X!Tandem-Kscore
modes with default settings. Then PeptideProphet (Keller
et al., 2002) and iProphet (Shteynberg et al., 2011) were
utilized to validate and integrate the peptide identification
results. ProteinProphet was finally employed to identify and
validate the proteins. For peptide and protein identification,
the probability of 0.95 was used as the threshold.
We then reassessed the coding capacity of those poten-
tially translatable ncRNAs using CPAT (Wang et al., 2013).
The candidate ncRNAs that were reassessed as protein-cod-
ing were excluded from further analyses. We further removed
those ncRNAs that were generated from protein-coding genes
or genomic patches. Through above stringent filtering, the re-
maining identified translatable ncRNAs were considered as
high-confidence candidates of bifunctional RNAs.
Expression profiling of bifunctional RNAs
We downloaded the gene/transcript expression matrix of
the GTEx project from its portal (http://www.gtexpor-
tal.org/home/), which included of 2,916 samples across 53
tissue sites (Lonsdale et al., 2013). Then expressions of
bifunctional RNAs were extracted from the GTEx expression
matrix. To investigate the expression profile of bifunctional
RNAs in early human embryos, we collected the single-cell
RNA-seq data of oocyte, pronucleus, zygote, 2-cell, 4-cell,
8-cell and morula stages from Gene Expression Omnibus
(GEO) (accession number: GSE44183) (Xue et al., 2013).
These RNA-seq data for a total of 29 samples were separately
mapped to the human genome GRCh37/hg19 using TopHat2
(Kim et al., 2013) (version 2.0.11) with parameter “–r=0”
based on the experimental design of the previous study.
Next, we quantified the expression of genes/transcripts in
each sample by employing Cufflinks (Trapnell et al., 2010)
(version 2.2.1) with parameters of “–u” and “–b” enabled
for correcting read mapping. Differential expression calling
between two adjacent stages was carried out using Cuffdiff2
(Trapnell et al., 2013) (version 2.2.1) with parameters of
“–b” and “–u” enabled as well.
Characterization and annotation of bifunctional RNAs
To examine the conservation of the bifunctional RNAs iden-
tified in our study, we downloaded the conserved elements
across 46 vertebrates predicted by phastCons (Siepel et al.,
2005) from UCSC Genome Browser. In order to investigate
the interactions between bifunctional RNAs and miRNA or
proteins, we obtained the interactions of miRNA-ncRNA and
protein-ncRNA from starBase v2.0 (Li et al., 2014) to con-
struct corresponding networks. We also examined the expres-
sion correlatio between bifunctional RNAs and their targeting
miRNAs using miRGator V3.0 (Cho et al., 2013) in different
cancer and normal tissues. To interrogate whether bifunc-
tional RNAs could act as ceRNAs to regulate the expression
of relevant genes, we checked their existence in the ceRNA
candidates cataloged in lnCeDB database (Das et al., 2014).
The cancer related genes of diverse human cancers from the
databases of NCG4.0 (An et al., 2014), TSGene (Zhao et
al., 2013) and two previous studies about human pan-can-
cer (Kandoth et al., 2013; Vogelstein et al., 2013) were col-
lected as well. We further inspected whether bifunctional
RNAs would function as ceRNA to influence the expression
of cancer genes by inquiring the miRNAs that could target
both cancer genes and bifunctional RNAs. The published dis-
ease/trait-associated GWAS variants were downloaded from
the National Human Genome Research Institute (NHGRI)
catalog (Welter et al., 2014). We also obtained the noncod-
ing somatic mutations of various cancers from the COSMIC
database (v71) (Ward and Kellis, 2012).
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